ASX:LSH

Lifespot Health Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume120,633 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive LSH News and Ratings via Email

Sign-up to receive the latest news and ratings for Lifespot Health and its competitors with MarketBeat's FREE daily newsletter.

About Lifespot Health

Lifespot Health Ltd provides diagnostic systems and delivery platforms to healthcare enterprises in Australia. The company is developing the BodyTel System that integrates multiple sensors for capturing diagnostic information for additional diseases; Seng-Vital, a Bluetooth enabled vaporizer and health platform designed for the use of medical cannabis; and FeverTel, a dual mode digital thermometer to record and track family's symptoms. Lifespot Health Ltd was incorporated in 2016 and is based in Melbourne, Australia.

Weed Week: Major shifts in US legislation set to open the door for some ASX cannabis stocks
June 5, 2021 | msn.com

BRIEF-Lifespot Health Requests Trading Halt
June 16, 2020 | www.reuters.com

BRIEF-Lifespot Health Says Platform Extended To Incorporate Bluetooth Enabled Thermometers
March 26, 2020 | uk.reuters.com

Lunchtime ASX small cap wrap: Who’s ready for a stimulus package today?
March 24, 2020 | www.msn.com

10 at 10: These 10 ASX stocks are looking primed for the rebound this morning
March 24, 2020 | www.msn.com

How Much Of Lifespot Health Ltd (ASX:LSH) Do Institutions Own?
March 24, 2020 | finance.yahoo.com

IONIC BRANDS Signs Heads of Agreement With Lifespot Health, Limited to Develop and Distribute Software and Vaporizer Technologies
March 24, 2020 | finance.yahoo.com

We're A Little Worried About Lifespot Health's (ASX:LSH) Cash Burn Rate
March 24, 2020 | finance.yahoo.com

The Lifespot Health (ASX:LSH) Share Price Is Down 53% So Some Shareholders Are Wishing They Sold
March 24, 2020 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange ASX
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
Current SymbolASX:LSH
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.lifespot-health.com
Phone61 3 9191 0135
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual Sales$22,476.00
Price / Sales0.00
Cash FlowN/A
Price / Cash Flow2.71
Book ValueA$0.02 per share
Price / BookN/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

1.24 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Lifespot Health.

4.5 Community Rank

Outperform Votes
Lifespot Health has received 11 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Lifespot Health has received 5 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Lifespot Health has received 68.75% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Lifespot Health and other stocks. Vote “Outperform” if you believe LSH will outperform the S&P 500 over the long term. Vote “Underperform” if you believe LSH will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Lifespot Health does not currently pay a dividend.
Dividend Growth
Lifespot Health does not have a long track record of dividend growth.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Lifespot Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought A$110,770.00 in company stock and sold A$0.00 in company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Lifespot Health (ASX:LSH) Frequently Asked Questions

What stocks does MarketBeat like better than Lifespot Health?

Wall Street analysts have given Lifespot Health a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Lifespot Health wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Lifespot Health's key executives?

Lifespot Health's management team includes the following people:

Mr. Matthew Golden, Chief Exec. Officer
Ms. Nova Anne Taylor, Company Sec.

Who are some of Lifespot Health's key competitors?

Some companies that are related to Lifespot Health include Australian Clinical Labs (ACL), BARD1 Life Sciences (BD1), Biomark Diagnostics (BUX), Charles River Laboratories International (CRL), Cryosite (CTE), dorsaVi (DVL), Epigenomics (EPGNY), Eternity Healthcare (ETAH), Genetic Signatures (GSS), Genetic Technologies (GTG), Imagin Medical (IME), Imagion Biosystems (IBX), Integral Diagnostics (IDX), Med BioGene (MBGNF) and Medical Imaging (MEDD).
View all of LSH's competitors.

What is Lifespot Health's stock symbol?

Lifespot Health trades on the ASX under the ticker symbol "LSH."

How much money does Lifespot Health make?

Lifespot Health has a market capitalization of $0.00 and generates $22,476.00 in revenue each year.

What is Lifespot Health's official website?

The official website for Lifespot Health is www.lifespot-health.com.

How can I contact Lifespot Health?

The company can be reached via phone at 61 3 9191 0135.

This page was last updated on 9/17/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.